MENU
PROK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ProKidney (PROK) Ownership - Who owns ProKidney?

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment... Show more

Profile

Industry
N/A
Address
2000 Frontis Plaza Boulevard
Phone
+1 336 999-7028
Employees
163
Web
https://www.prokidney.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
323.43M
P/E Ratio
N/A
Total Cash
294.73M
Projected Growth
N/A
Total Debt
4.42M
Revenue
527K
Risk (Beta)
3.21
Dividend Yield
N/A
Total Cash/Share
2.08
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price

Fundamentals

PROK
Capitalization
323M
P/E Ratio
N/A
Risk (Beta)
3.21
Dividend Yield
N/A
Total Cash
295M
Total Cash/Share
2.08
Total Debt
4.42M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
527K
ROE
N/A
Book Value
-1B
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.56
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
29K
Current Ratio
11.48
Current Revenue Per Employee
1083.33
Dividends Per Share - Security
N/A
EBITDA
-157.52M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-16.64
Shares Held By Institutions
160M
Shares Outstanding - Current
142M
Total Liabilities
32.7M
Total Volume MTD
N/A
Value
-1
Gain YTD
34.911
View a ticker or compare two or three
PROK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2000 Frontis Plaza Boulevard
Phone
+1 336 999-7028
Employees
163
Web
https://www.prokidney.com